| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 4005377 | American Journal of Ophthalmology | 2008 | 7 Pages |
Abstract
We present evidence that conjunctival and corneal melanoma regresses after exposure to topical interferon alfa-2b. A larger-scale longer-term study must evaluate the long-term efficacy and safety of this therapy.
Related Topics
Health Sciences
Medicine and Dentistry
Ophthalmology
Authors
Paul T. Finger, Ragui W. Sedeek, Kimberly J. Chin,